Israel Englander Guardant Health, Inc. Call Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $223,000 - $362,900	10,000 Added 25.0%	50,000 $1.15 Million
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $408,178 - $808,736	25,400 Added 173.97%	40,000 $1.16 Million
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $263,802 - $414,414	-15,400 Reduced 51.33%	14,600 $301,000
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $647,400 - $885,000	30,000 New	30,000 $811,000
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $229,200 - $337,600	10,000 New	10,000 $234,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.